Subungual melanoma is a rare variant of acral lentiginous melanoma that often has a poor prognosis compared with other types of melanoma. The aim of the present study is to report a case of a patient with recurrence of subungual melanoma treated with imiquimod 5%, which presented a total regression of the lesion and no recurrence for 4 years
Subungual melanoma is a distinct subtype of cutaneous malignant melanoma arising from structures wit...
Background Melanoma in situ (MIS) occurs on various body sites, in various age groups, and is manage...
Surgical excision represents the primary treatment for malignant melanoma. On occasion, however, sur...
Subungual melanoma is a rare malignant tumor, little known to practitioners. Its location makes diag...
Subungual melanoma (SUM) is infrequent in the general population, accounting for 0.7-3.5% of all cut...
Subungual melanoma (SUM) is an uncommon variant of melanoma that is often difficult to diagnose, bot...
Subungual melanoma is a rare malignant neoplasm of melanocytes that arises from the nail matrix. In ...
Topical imiquimod is a medication approved for the treatment of external genital and perianal warts,...
Summary: We present a brief literature review of the topical immune-modulating medication Imiquimod....
BRAVO, Erick A., PAÚCAR, Silvia, PAREDES, Guido [et al.]. Melanoma subungueal in situ: reporte de do...
Subungual melanoma (SUM) is an uncommon form of acral melanoma that arises within the nail matrix. T...
Lentigno maligna is a melanoma in situ that most commonly appears on areas exposed to ultraviolet ra...
Melanoma of the ungual apparatus represents less than 3% of all cases of cutaneous melanoma.1 To our...
Lentigo maligna (LM) is the in situ phase of lentigo maligna melanoma, which may progress to invasiv...
Lentigo maligna (LM) is an in situ variant of melanoma. Our objective was to systematically review c...
Subungual melanoma is a distinct subtype of cutaneous malignant melanoma arising from structures wit...
Background Melanoma in situ (MIS) occurs on various body sites, in various age groups, and is manage...
Surgical excision represents the primary treatment for malignant melanoma. On occasion, however, sur...
Subungual melanoma is a rare malignant tumor, little known to practitioners. Its location makes diag...
Subungual melanoma (SUM) is infrequent in the general population, accounting for 0.7-3.5% of all cut...
Subungual melanoma (SUM) is an uncommon variant of melanoma that is often difficult to diagnose, bot...
Subungual melanoma is a rare malignant neoplasm of melanocytes that arises from the nail matrix. In ...
Topical imiquimod is a medication approved for the treatment of external genital and perianal warts,...
Summary: We present a brief literature review of the topical immune-modulating medication Imiquimod....
BRAVO, Erick A., PAÚCAR, Silvia, PAREDES, Guido [et al.]. Melanoma subungueal in situ: reporte de do...
Subungual melanoma (SUM) is an uncommon form of acral melanoma that arises within the nail matrix. T...
Lentigno maligna is a melanoma in situ that most commonly appears on areas exposed to ultraviolet ra...
Melanoma of the ungual apparatus represents less than 3% of all cases of cutaneous melanoma.1 To our...
Lentigo maligna (LM) is the in situ phase of lentigo maligna melanoma, which may progress to invasiv...
Lentigo maligna (LM) is an in situ variant of melanoma. Our objective was to systematically review c...
Subungual melanoma is a distinct subtype of cutaneous malignant melanoma arising from structures wit...
Background Melanoma in situ (MIS) occurs on various body sites, in various age groups, and is manage...
Surgical excision represents the primary treatment for malignant melanoma. On occasion, however, sur...